how much is enough?

That's a big question all of us should be asking... Will they have enough cash to get over the line, if big pharma doesn't decides not to buy into the target drug CXS are developing.

The talk on other forums reminds us that we could be nearing the peak of another bear-market rally. If the market turns tail once more, so will cxs, great prospects or not. Don't get me wrong, I like the look of this stock, but I wonder how much more dilution will the market take?